Biotechnology Companies By Working Capital
LargestBiggest EarnersMost ProfitableMost LiquidHighly LeveragedTop DividendsCapital-HeavyHighest ValuationLargest Workforce
Working Capital
| Working Capital | Efficiency | Market Risk | Exp Return | ||||
|---|---|---|---|---|---|---|---|
| 1 | ORKA | Oruka Therapeutics, | (0.14) | 5.01 | (0.72) | ||
| 2 | GMAB | Genmab AS | (0.03) | 2.79 | (0.09) | ||
| 3 | BNTX | BioNTech SE | (0.06) | 3.29 | (0.21) | ||
| 4 | REGN | Regeneron Pharmaceuticals | (0.09) | 2.08 | (0.18) | ||
| 5 | GILD | Gilead Sciences | 0.15 | 1.60 | 0.25 | ||
| 6 | ROIV | Roivant Sciences | (0.09) | 1.91 | (0.18) | ||
| 7 | VRTX | Vertex Pharmaceuticals | 0.25 | 1.50 | 0.37 | ||
| 8 | AMGN | Amgen Inc | 0.18 | 1.53 | 0.28 | ||
| 9 | MRNA | Moderna | (0.03) | 5.33 | (0.16) | ||
| 10 | ARGX | argenx NV ADR | (0.03) | 1.66 | (0.06) | ||
| 11 | GRFS | Grifols SA ADR | (0.01) | 2.77 | (0.03) | ||
| 12 | GLPG | Galapagos NV ADR | (0.05) | 2.05 | (0.10) | ||
| 13 | UTHR | United Therapeutics | (0.09) | 2.31 | (0.21) | ||
| 14 | BMRN | Biomarin Pharmaceutical | 0.07 | 1.65 | 0.12 | ||
| 15 | SRPT | Sarepta Therapeutics | (0.17) | 4.42 | (0.75) | ||
| 16 | IONS | Ionis Pharmaceuticals | (0.06) | 2.64 | (0.16) | ||
| 17 | RVMD | Revolution Medicines | (0.10) | 2.50 | (0.24) | ||
| 18 | RVMDW | Revolution Medicines, Warrant | 0.06 | 21.80 | 1.26 | ||
| 19 | ALNY | Alnylam Pharmaceuticals | 0.10 | 3.00 | 0.29 | ||
| 20 | BIIB | Biogen Inc | (0.06) | 1.72 | (0.11) |
The analysis above is based on a 90-day investment horizon and a default level of risk. Use the Portfolio Analyzer to fine-tune all your assumptions. Check your current assumptions here.
Working Capital is a measure of company efficiency and operating liquidity. The working capital is usually calculated by subtracting Current Liabilities from Current Assets. It is an important indicator of the firm ability to continue its normal operations without additional debt obligations. .Working Capital can be positive or negative, depending on how much of current debt the company is carrying on its balance sheet. In general terms, companies that have a lot of working capital will experience more growth in the near future since they can expand and improve their operations using existing resources. On the other hand, companies with small or negative working capital may lack the funds necessary for growth or future operation. Working Capital also shows if the company has sufficient liquid resources to satisfy short-term liabilities and operational expenses.